Carregant...

Pre-Therapeutic Total Lesion Glycolysis on [(18)F]FDG-PET Enables Prognostication of 2 Year Progression-Fee Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based Immunotherapy

PURPOSE: Standardized uptake values (SUV), total metabolic tumor volumes (TMTV), and total lesion glycolysis (TLG) based on positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG/positron emission tomography (PET) are established outcome predictors in FDG-avid lymphomas. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Imaging Biol
Autors principals: Mayerhoefer, Marius E., Staudenherz, Anton, Kiesewetter, Barbara, Weber, Michael, Simonitsch-Klupp, Ingrid, Gibbs, Peter, Dolak, Werner, Lukas, Julius, Raderer, Markus
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604829/
https://ncbi.nlm.nih.gov/pubmed/30847823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-019-01329-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!